Cargando…
Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
TKI therapy has shown excellent efficacy and favorable tolerability in patients with mutation-positive nonsmall cell lung cancer. However, there is no clear consensus on the role of TKI as induction therapy. In this article, we reviewed recently published studies to analyze the benefits of tyrosine...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752212/ https://www.ncbi.nlm.nih.gov/pubmed/33165003 http://dx.doi.org/10.1097/CCO.0000000000000696 |